MicroHeal (formerly WinHealth )

What MicroHeal (formerly WinHealth ) does

MicroHeal (formerly WinHealth), legally Microheal Wellness Private Limited, is an Ahmedabad, India-based digital therapeutics company operating a Hybrid Drug Therapy platform that combines prescription medications (Rx) with personalized digital therapeutics (DTx) for chronic condition management. Founded in 2023 and operating with roughly 8 employees, the company delivers an integrated stack: the core MicroHeal Platform serves as an intelligent clinical dashboard with EHR integration; the HealOGut mobile app provides patient-facing digital care, symptom tracking, and 24/7 health assistant support; and modular sub-products include the Prescription-DTx Integration Platform, Clinical Data Intelligence, IoT Device Integration Platform, Advanced Analytics Engine, Digital Therapeutics Framework, and a Real-World Evidence Engine targeted at pharmaceutical partners. The platform is positioned as Asia's first clinically validated Rx+DTx solution backed by a randomized controlled trial and covers 25+ therapeutic areas spanning gastroenterology, oncology, cardiovascular and metabolic, autoimmune and inflammatory, and mental health and neurology. Upcoming products include the GutSense Pro gastrointestinal monitor, a Smart Health Watch, and IoT Health Monitoring Devices.

The business model is multi-channel. Enterprise revenue is driven by B2B licensing of the platform to hospitals and pharmaceutical companies under subscription/recurring arrangements, with quote-based enterprise pricing and a "zero upfront investment" hospital adoption offer. Direct-to-consumer reach is enabled through the HealOGut app on Google Play and Apple App Store, targeting patients with chronic conditions. Go-to-market combines enterprise field sales with "Book Demo" CTAs, channel partnerships with hospitals embedding digital therapeutics into clinical workflows, content marketing on LinkedIn and Medium, and app store distribution. The company claims 2,000+ patients treated, 40+ gastroenterologists onboarded, 18 countries with active deployments, and adoption by 3 in 4 top-20 pharma companies, though no revenue, funding rounds, or named enterprise customers are publicly disclosed. Ownership is private and founder-led with no disclosed institutional investors, parent company, or M&A activity.

Name

MicroHeal (formerly WinHealth )

Legal name

Microheal Wellness Private Limited

Website

https://microheal.in

Company type

Private

Operating status

Operating

Headcount range

1–10 employees

Short description

MicroHeal is an India-based digital therapeutics company that combines prescription medications with digital therapeutics (Rx+DTx) to deliver the Hybrid Drug Therapy platform for hospitals, pharmaceutical companies, and patients managing chronic gastrointestinal, oncology, cardiovascular, autoimmune, and mental health conditions.

Ownership category

akta.pro rank

Product category

Digital Therapeutics Healthcare Software

NAICS

Other Ambulatory Health Care Services (6219), All Other Outpatient Care Centers (621498)

SIC

Services-Prepackaged Software (7372), Services-Home Health Care Services (8082)

akta.pro primary industry

Medication Adherence, Digital Therapeutics & Remote Coaching (condition-specific programs) (HLALAFAF)

akta.pro secondary industries

Condition-specific Digital Therapeutics (DTx) (HLACANAA), Cardiometabolic RPM & Chronic Disease Management (diabetes, hypertension, CHF, obesity) (HLALAFAA)

Keywords

• Digital therapeutics
• Hybrid drug therapy
• Chronic care management
• Healthcare data analytics
• Medication adherence

Headquarters

HQ city

Ahmedabad

HQ country

India

HQ region

Asia

Offices1 record

Markets served

GTM type

B2B and B2C

Offering type

Software

Cost components

Technology or R&D, Operations, Personnel, Marketing or Sales, Infrastructure

Revenue model

1. Enterprise Platform Licensing: B2B licensing of the Hybrid Drug Therapy platform to pharmaceutical companies and hospitals for patient management, clinical trials, and real-world evidence generation.
2. Direct-to-Consumer App Services: Mobile application distributed through app stores targeting patients with chronic conditions, providing personalized digital care programs.

Go-to-market motion3 records

Distribution channels4 records

Marketing channels5 records

Core offering

MicroHeal fundamentally sells a Hybrid Drug Therapy platform that combines prescription medications (Rx) with clinically validated Digital Therapeutics (DTx) for chronic condition management. The offering includes a hospital-facing unified clinical dashboard, a Prescription-DTx Integration Platform for pharmaceutical companies, an IoT Device Integration Platform, an AI-powered Clinical Data Intelligence layer, and the HealOGut patient mobile application. It is delivered to hospitals under zero upfront investment terms and to patients via consumer app stores, supported by dedicated care team services.

Product overview

MicroHeal is a digital therapeutics company offering a unified platform-plus-modules architecture centered on its Hybrid Drug Therapy model (Rx + DTx). The core MicroHeal Platform serves as an intelligent dashboard connecting patients, data, and care teams. For hospitals, it provides Digital Therapeutics Solutions with integrated care pathways, continuous patient engagement, and clinical dashboards. For pharmaceutical partners, it offers the Prescription-DTx Integration Platform alongside specialized solutions including Clinical Data Intelligence, the IoT Device Integration Platform, Advanced Analytics Engine, Digital Therapeutics Framework, and Real-World Evidence Engine. The patient-facing HealOGut mobile app delivers personalized digital care programs. Upcoming products include GutSense Pro (gastrointestinal monitoring) and Smart Health Watch (wearable). The platform covers 25+ therapeutic areas spanning gastroenterology, oncology, cardiovascular & metabolic, autoimmune & inflammatory, and mental health & neurology. Care team services include nutrition experts, behavioral health specialists, dedicated care managers, and 24/7 digital health assistant.

Differentiator

Problem solved

Functional benefit

Products and services

• MicroHeal Hospital Platform An intelligent unified dashboard and digital therapeutics platform for hospitals and specialists to deliver hybrid prescription-plus-digital-therapeutic care, reduce relapse, and improve long-term patient engagement under zero upfront investment with easy integration into existing healthcare infrastructure.
• Prescription-DTx Integration Platform (Rx + DTx) An integrated platform for pharmaceutical companies that seamlessly combines prescription medications (Rx) with evidence-based digital therapeutics (DTx) to enhance drug efficacy, improve adherence, and generate connected care across multiple therapeutic areas.
• Clinical Data Intelligence An AI-powered analytics platform that processes multi-source health data to enable risk prediction, treatment optimization, and measurable outcome tracking across therapeutic programs.
• IoT Device Integration Platform A connectivity platform that integrates IoT-enabled health monitoring devices to bring continuous real-world patient data into the MicroHeal digital therapeutics ecosystem.
• HealOGut Mobile App A patient-facing mobile application that provides microlearning content, behavior-change programs, and a 24/7 digital health assistant to support individuals managing chronic conditions, particularly gut-related health issues, alongside their prescribed care.
• Care Team Services A dedicated care team service that combines AI-powered efficiency with human expertise to deliver personalized patient care and support across the MicroHeal platform.
• Therapeutic Area Digital Therapeutics Solutions Specialized digital therapeutics implementations of MicroHeal's hybrid platform across five therapeutic areas: Gastroenterology, Oncology, Cardiovascular and Metabolic, Autoimmune and Inflammatory, and Mental Health and Neurology, each tailored to the unique clinical and behavioral needs of the condition.
• Hybrid Drug Therapy MicroHeal's core care model that combines targeted prescription medication (Rx) with personalized Digital Therapeutics (DTx), integrating clinically validated digital tools and behavioral programs with pharmaceutical interventions for holistic, data-driven chronic condition management.

Quantifiable outcome

• 88% reduction in physiological symptoms
• +6 more outcomes

Named customers1 record

Segments8 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration4 records

AI capability7 records

Feature6 records

Scale indicators16 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Akili Interactive: Prescription digital therapeutic company (EndeavorRx) with FDA-cleared software, pharma commercialization, and clinical validation. Comparable DTx regulatory and pharma-distribution model.
• Virta Health: Diabetes reversal and metabolic condition platform combining telehealth, continuous monitoring, and behavioral coaching. Comparable chronic-condition digital therapeutic positioning with strong clinical outcomes claims.
• DarioHealth: Chronic condition digital health platform spanning diabetes, hypertension, musculoskeletal and behavioral health with connected devices. Comparable multi-condition DTx plus device ecosystem.
• Omada Health: Virtual chronic condition management (diabetes, hypertension, behavioral health) combining digital coaching with connected devices. Comparable multi-condition platform with B2B payer/employer sales motion.
• Propeller Health (ResMed): Digital therapeutic platform for respiratory disease pairing connected inhalers with a software app; pharma partnerships. Comparable Rx + connected-device + DTx hybrid model with real-world evidence generation.
• Click Therapeutics: US-based prescription digital therapeutics company combining software with pharma partnerships and clinical validation. Closely comparable to MicroHeal's Hybrid Rx + DTx model and pharma-anchored commercialization approach.
• WellDoc: Chronic disease digital therapeutics platform (BlueStar for diabetes) integrating with EHRs and pharma. Comparable to MicroHeal's prescription-DTx integration, clinical dashboards, and chronic-condition focus.
• Better Therapeutics: Digital therapeutics company developing prescription software for cardiometabolic conditions (type 2 diabetes, hypertension). Directly comparable to MicroHeal's cardiovascular & metabolic platform with FDA SaMD pathway.
• Voluntis (AstraZeneca): Digital therapeutics company (now part of AstraZeneca) embedding software into pharma therapies for oncology and chronic disease. Comparable Rx + DTx integration with pharma-anchored distribution.

Emerging players

• Kaia Health: Digital therapeutics for chronic pain (back, MSK) with self-serve app distribution and clinical evidence. Comparable DTx with app-store GTM, though narrower therapeutic scope than MicroHeal.

Market position

Strengths5 records

Weaknesses4 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/win-health

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about MicroHeal (formerly WinHealth )